PLEASANTON, CA,– Gatan – a leading manufacturer of instrumentation and software used to enhance the performance of electron microscopes – and DECTRIS – the industry leader in hybrid-pixel X-ray and electron detectors for science and industry – today announced the signing of a joint sales and service agreement pertaining to the use of DECTRIS technology […]
Collaboration across leading academic institutions and industry to create data coordinating center to advance understanding of Down syndrome and its co-occurring medical conditions BOSTON – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced participation in the Data Management and Portal for INCLUDE (DAPI) Project, which will create a world class platform for data sharing, data access, and […]
Expanding laboratory dioxin testing with the latest technology SANTA CLARA, Calif.– Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the future regulation and detection of dioxins. Dioxins are a group of chemical compounds […]
Thermo Fisher and the Biopharmaceutical Analysis Training Laboratory (BATL) of Northeastern University aim to deliver cutting-edge analytical solutions and training programs San Jose, Calif. – Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative agreement in a bid to advance […]
Sales, support, and training for QLIMS in the DACH region Cologne / Bonn, Germany. The LIMS software from Australian software provider OnQ Software is now also available in Germany: The two partner companies MEDEORA and LIMS at work are responsible for acquiring new customers for QLIMS in Germany, Austria, and Switzerland (DACH). Their services also […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) has announced the signing of a memorandum of understanding (MOU) with GI Innovation (GII), a Korean clinical-stage biopharmaceutical company. The MOU establishes a framework in which the two companies will enter into a strategic partnership to explore potential genomic biomarkers of the tumor microenvironment in an early-phase […]
Amsterdam, the Netherlands — 30 October 2020 — LUMICKS is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen receptor (CAR) T-cells using the […]
EpiTect Hi-C Kit helps researchers to better understand key aspects of long-range genome architecture License agreement enables QIAGEN to sell Phase Genomics’ proprietary proximity-ligation technology in the United States research market Adds to QIAGEN’s epigenomic capabilities in identification of individual methylation marks and histone modification at the nucleotide level Hilden, Germany, and Germantown, Maryland – QIAGEN […]
Thermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows SAN JOSE, Calif. – Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, […]
Agency-wide CRADA agreement also includes studies with Brain-Chip in Alzheimer’s disease, Intestine-Chip in microbiome health, and Liver-Chip in individualized toxicity responses BOSTON, Mass. — Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration (FDA) to enable multiple studies across FDA offices in […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
